Presents the results of a randomized phase III trial to determine whether topically applied retinoic acid reversed moderate cervical intraepithelial neoplasia (CIN) II or severe CIN. Patient eligibility; Histological classification of dysplasia; Biopsy-cytology evaluation; Therapeutic regimen; Drug requirements and delivery; RA administration; Toxicity.